SCHEMBL3200802

SCHEMBL3200802

CNc1ccc(-c2nc3ccc(OC)cc3o2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.69
TP53 P04637 4/20 0.64
MAPT P10636 6/20 0.58
LMNA P02545 2/20 0.58
HDAC6 Q9UBN7 1/20 0.57
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
POLB P06746 1/20 0.56
THRB P10828 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
PTPN2 P17706 4/20 0.51
PTPN1 P18031 4/20 0.51
PTPN5 P54829 4/20 0.51
HSPD1 P10809 1/20 0.51
HSPE1 P61604 1/20 0.51
KDM4E B2RXH2 1/20 0.50
USP2 O75604 1/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22047116 0.85 APP (0.52) APPTP53MAPTLMNAHDAC6
SCHEMBL11835372 0.84 TP53 (0.63) APPTP53MAPTLMNAHDAC6
SCHEMBL18726400 0.83 TLR7 (0.58) APPTP53MAPTSMN1; SMN2POLB
SCHEMBL29364586 0.83 APP (0.61) APPTP53MAPTLMNAHDAC6
SCHEMBL28509208 0.83 APP (0.61) APPTP53MAPTLMNAHDAC6
SCHEMBL16894043 0.83 APP (0.61) APPTP53MAPTLMNAHDAC6
SCHEMBL3905723 0.82 APP (0.60) APPTP53MAPTLMNAHDAC6
SCHEMBL3905720 0.82 APP (0.60) APPTP53MAPTLMNAHDAC6
SCHEMBL3188005 0.82 APP (1.00) APPTP53MAPTLMNAHDAC6
SCHEMBL15080531 0.81 NPC1 (0.68) APPTP53MAPTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7670591-B2 Heteroaryl substituted benzoxazoles ASTRAZENECA AB (SE) 2010-03-02 US disclosed
EP-2035418-A1 NOVEL HETEROARYL SUBSTITUTED BENZOXAZOLES Astra Zeneca AB (SE) 2009-03-18 EP disclosed
US-20080027051-A1 Novel Heteroaryl Substituted Benzoxazoles ASTRAZENECA AB (SE) 2008-01-31 US disclosed
WO-2007149030-A1 NOVEL HETEROARYL SUBSTITUTED BENZOXAZOLES ASTRAZENECA AB (SE) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027051-A1 Novel Heteroaryl Substituted Benzoxazoles PSEN1, PSEN2, APP APP 3/4885TP53 3807/4885MAPT 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.